CME Group (NASDAQ:CME) Trading Up 7.4% Following Better-Than-Expected Earnings

Shares of CME Group Inc. (NASDAQ:CME) shot up 7.4% during mid-day trading on Wednesday following a better than expected earnings announcement. The company traded as high as $254.02 and last traded at $254.9870. Approximately 465,151 shares were traded during mid-day trading, a decline of 83% from the average daily volume of 2,750,870 shares. The stock had previously closed at $237.38.

The financial services provider reported $2.99 earnings per share for the quarter, topping the consensus estimate of $2.91 by $0.08. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The company had revenue of $1.71 billion during the quarter, compared to analyst estimates of $1.68 billion. During the same quarter last year, the business posted $2.96 earnings per share. The company’s revenue was up .8% on a year-over-year basis.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th were given a dividend of $1.30 per share. The ex-dividend date was Tuesday, June 9th. This represents a $5.20 dividend on an annualized basis and a yield of 2.0%. CME Group’s dividend payout ratio is presently 44.37%.

Key Stories Impacting CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME Group beat quarterly earnings and revenue estimates, signaling resilient demand for its derivatives and clearing services. CME Group (CME) Q2 Earnings and Revenues Top Estimates
• Positive Sentiment: Trading volume was a key tailwind in the quarter, with one report saying CME posted its second-highest volume ever, helping drive stronger-than-expected results. CME Group Q2 earnings beat, buoyed by second-highest trading volume
• Positive Sentiment: The company also reported operating income of roughly $1.1 billion, underscoring strong profitability in the quarter. CME Group Inc. Reports Strong Financial Results for Q2 2026

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the stock. Morgan Stanley lowered their price target on shares of CME Group from $353.00 to $324.00 and set an “overweight” rating for the company in a research report on Friday, July 10th. Raymond James Financial restated an “outperform” rating and issued a $320.00 price objective on shares of CME Group in a report on Thursday, July 2nd. The Goldman Sachs Group reduced their price objective on shares of CME Group from $267.00 to $245.00 and set a “sell” rating on the stock in a research note on Tuesday, June 30th. Deutsche Bank Aktiengesellschaft lowered their target price on shares of CME Group from $342.00 to $322.00 and set a “buy” rating for the company in a report on Thursday, April 23rd. Finally, Jefferies Financial Group dropped their target price on shares of CME Group from $356.00 to $349.00 and set a “buy” rating for the company in a research report on Thursday, April 9th. Twelve analysts have rated the stock with a Buy rating, four have given a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, CME Group currently has an average rating of “Moderate Buy” and an average price target of $292.12.

Insider Buying and Selling

In other CME Group news, insider Hilda Harris Piell sold 5,753 shares of CME Group stock in a transaction dated Monday, May 18th. The stock was sold at an average price of $304.63, for a total value of $1,752,536.39. Following the sale, the insider owned 27,702 shares of the company’s stock, valued at $8,438,860.26. This trade represents a 17.20% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Terrence A. Duffy sold 35,000 shares of the firm’s stock in a transaction that occurred on Friday, May 15th. The stock was sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the transaction, the chief executive officer directly owned 55,630 shares of the company’s stock, valued at $16,606,111.30. This represents a 38.62% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Company insiders own 0.30% of the company’s stock.

Institutional Investors Weigh In On CME Group

Several institutional investors and hedge funds have recently added to or reduced their stakes in CME. Asset Dedication LLC raised its holdings in CME Group by 64.9% during the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 37 shares in the last quarter. Whipplewood Advisors LLC grew its stake in CME Group by 2,075.0% in the first quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 83 shares in the last quarter. FNY Investment Advisers LLC bought a new position in CME Group in the fourth quarter valued at approximately $27,000. Elkhorn Partners Limited Partnership acquired a new position in shares of CME Group during the 4th quarter worth approximately $27,000. Finally, Hilton Head Capital Partners LLC acquired a new position in shares of CME Group during the 4th quarter worth approximately $28,000. 87.75% of the stock is owned by institutional investors.

CME Group Price Performance

The stock has a market cap of $91.97 billion, a price-to-earnings ratio of 21.67, a price-to-earnings-growth ratio of 3.05 and a beta of 0.25. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The company has a 50-day simple moving average of $256.83 and a two-hundred day simple moving average of $281.68.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.